177 related articles for article (PubMed ID: 35760104)
1. Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity.
Saffi GT; Wang CA; Mangialardi EM; Vacher J; Botelho RJ; Salmena L
J Biol Chem; 2022 Aug; 298(8):102187. PubMed ID: 35760104
[TBL] [Abstract][Full Text] [Related]
2. Sequential conversion of PtdIns3P to PtdIns(3,5)P
Rodgers SJ; Jones EI; Mitchell CA; McGrath MJ
Autophagy; 2023 Apr; 19(4):1365-1367. PubMed ID: 36103410
[TBL] [Abstract][Full Text] [Related]
3. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
[TBL] [Abstract][Full Text] [Related]
4. Active vacuolar H+ ATPase and functional cycle of Rab5 are required for the vacuolation defect triggered by PtdIns(3,5)P2 loss under PIKfyve or Vps34 deficiency.
Compton LM; Ikonomov OC; Sbrissa D; Garg P; Shisheva A
Am J Physiol Cell Physiol; 2016 Sep; 311(3):C366-77. PubMed ID: 27335171
[TBL] [Abstract][Full Text] [Related]
5. Class III PI 3-kinase is the main source of PtdIns3P substrate and membrane recruitment signal for PIKfyve constitutive function in podocyte endomembrane homeostasis.
Ikonomov OC; Sbrissa D; Venkatareddy M; Tisdale E; Garg P; Shisheva A
Biochim Biophys Acta; 2015 May; 1853(5):1240-50. PubMed ID: 25619930
[TBL] [Abstract][Full Text] [Related]
6. PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells.
Roy A; Chakraborty AR; Nomanbhoy T; DePamphilis ML
Autophagy; 2023 Sep; 19(9):2464-2484. PubMed ID: 36803256
[TBL] [Abstract][Full Text] [Related]
7. Insights into Lysosomal PI(3,5)P
Lees JA; Li P; Kumar N; Weisman LS; Reinisch KM
Mol Cell; 2020 Nov; 80(4):736-743.e4. PubMed ID: 33098764
[TBL] [Abstract][Full Text] [Related]
8. PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis.
Ikonomov OC; Sbrissa D; Fenner H; Shisheva A
J Biol Chem; 2009 Dec; 284(51):35794-806. PubMed ID: 19840946
[TBL] [Abstract][Full Text] [Related]
9. Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence.
Choy CH; Saffi G; Gray MA; Wallace C; Dayam RM; Ou ZA; Lenk G; Puertollano R; Watkins SC; Botelho RJ
J Cell Sci; 2018 May; 131(10):. PubMed ID: 29661845
[TBL] [Abstract][Full Text] [Related]
10. Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex.
Sbrissa D; Ikonomov OC; Fu Z; Ijuin T; Gruenberg J; Takenawa T; Shisheva A
J Biol Chem; 2007 Aug; 282(33):23878-91. PubMed ID: 17556371
[TBL] [Abstract][Full Text] [Related]
11. A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis.
Sharma G; Guardia CM; Roy A; Vassilev A; Saric A; Griner LN; Marugan J; Ferrer M; Bonifacino JS; DePamphilis ML
Autophagy; 2019 Oct; 15(10):1694-1718. PubMed ID: 30806145
[TBL] [Abstract][Full Text] [Related]
12. The Lipid Kinase PIKfyve Coordinates the Neutrophil Immune Response through the Activation of the Rac GTPase.
Dayam RM; Sun CX; Choy CH; Mancuso G; Glogauer M; Botelho RJ
J Immunol; 2017 Sep; 199(6):2096-2105. PubMed ID: 28779020
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.
Fernandez-Mosquera L; Yambire KF; Couto R; Pereyra L; Pabis K; Ponsford AH; Diogo CV; Stagi M; Milosevic I; Raimundo N
Autophagy; 2019 Sep; 15(9):1572-1591. PubMed ID: 30917721
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lysosomal phosphoinositide balance by INPP5E is essential for autophagosome-lysosome fusion.
Nakamura S; Hasegawa J; Yoshimori T
Autophagy; 2016 Dec; 12(12):2500-2501. PubMed ID: 27715391
[TBL] [Abstract][Full Text] [Related]
15. PIKfyve activity regulates reformation of terminal storage lysosomes from endolysosomes.
Bissig C; Hurbain I; Raposo G; van Niel G
Traffic; 2017 Nov; 18(11):747-757. PubMed ID: 28857423
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
17. The Fab1/PIKfyve phosphoinositide phosphate kinase is not necessary to maintain the pH of lysosomes and of the yeast vacuole.
Ho CY; Choy CH; Wattson CA; Johnson DE; Botelho RJ
J Biol Chem; 2015 Apr; 290(15):9919-28. PubMed ID: 25713145
[TBL] [Abstract][Full Text] [Related]
18. Changing phosphoinositides "on the fly": how trafficking vesicles avoid an identity crisis.
Botelho RJ
Bioessays; 2009 Oct; 31(10):1127-36. PubMed ID: 19708025
[TBL] [Abstract][Full Text] [Related]
19. Apilimod, a candidate anticancer therapeutic, arrests not only PtdIns(3,5)P2 but also PtdIns5P synthesis by PIKfyve and induces bafilomycin A1-reversible aberrant endomembrane dilation.
Sbrissa D; Naisan G; Ikonomov OC; Shisheva A
PLoS One; 2018; 13(9):e0204532. PubMed ID: 30240452
[TBL] [Abstract][Full Text] [Related]
20. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
